Earnings Call · Q4 FY2022·2023-03-21

Q4 22EPS -46.15%·Rev n/aQ3 22EPS +43.75%·Rev n/aQ2 22EPS -50.00%·Rev n/aQ1 22EPS 0.00%·Rev n/a⚠ consensus missing

Sanara MedTech Inc. SMTI

Callon Nichols — Investor Relations

Ron Nixon — Chief Executive Officer

Zachary Fleming — Vice President of Sales

Mike McNeil — Chief Financial Officer

−0.9%1d on move date−0.8% vs SPY3d+0.8%5d+0.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SMTI calls or request research access.

More SMTI calls Browse calls Request research access